KDventures AB
2I9
Company Profile
Business description
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
Contact
Nanna Svartz vag 6A
Solna171 65
SWET: +46 852486070
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
7
Stocks News & Analysis
stocks
Jet fuel price spike weighing on Australian airline profits
Fuel volatility can lead to short-term earnings swings but all players bear the cost almost equally.
stocks
US utilities stocks keep rallying as investors bet on power demand growth
Rising electricity demand from data centers supports earnings growth, but Morningstar analysts say the sector looks less attractive after a sharp rally.
stocks
What did Morningstar subscribers buy and sell during March?
How the most traded shares in March stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,181.10 | 29.10 | -0.32% |
| CAC 40 | 8,276.95 | 50.91 | -0.61% |
| DAX 40 | 24,063.59 | 19.37 | 0.08% |
| Dow JONES (US) | 48,535.99 | 317.74 | 0.66% |
| FTSE 100 | 10,615.17 | 6.11 | 0.06% |
| HKSE | 25,947.32 | 75.00 | 0.29% |
| NASDAQ | 23,639.08 | 455.35 | 1.96% |
| Nikkei 225 | 58,134.24 | 256.85 | 0.44% |
| NZX 50 Index | 13,076.58 | 59.32 | 0.46% |
| S&P 500 | 6,967.38 | 81.14 | 1.18% |
| S&P/ASX 200 | 8,978.70 | 32.70 | -0.36% |
| SSE Composite Index | 4,027.21 | 0.58 | 0.01% |